ArticleAnnals of hepato-biliary-pancreatic surgery2024

Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer.

Evelyn Waugh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.